ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Despite animal studies demonstrating profound and sustainable weight reduction and amelioration of insulin resistance [24], the vision of providing an adiponectin adjunct against human obesity and insulin resistance has not been transcended into clinical trials.